Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Oslo | OTHER |
| University of Oxford | OTHER |
| Karolinska Institutet | OTHER |
| Wichita State University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Depression (major depressive disorder; MDD) is a very common mental disorder. Research suggests that individuals with prior depressive episodes have a risk of the relapse or recurrence of MDD. Secondary prevention has been identified as a key goal in the long-term management of the disease. The current project aims to investigate whether group based Acceptance and Commitment Therapy (ACT) can reduce surrogate and clinical markers of relapse in a group highly vulnerable to depressive episodes. The group intervention will consist of eight sessions, and each group will consist of maximum 12 persons. The project also studies whether Attention Bias Modification (ABM) preceding the ACT intervention will enhance the effect. ABM will be administered over a fourteen days period prior to the ACT-intervention. Effect will be measured over a period of 12 months. The primary outcome is changes in depressive symptoms. ACT-specific secondary outcome measures are also included. Subjects with a history of major depression (n=200), currently in remission, will be recruited from Sørlandet Hospital (100 participants). Matched participants (100 participants) will be recruited at the University of Oslo. In the first phase, participants from Sørlandet hospital will be randomized to ABM treatment or control condition. In the second phase all participants from Sørlandet hospital will receive group based ACT treatment. Group based ACT and ABM represent interventions that are time and cost effective, and that could be made available to large number of individuals struggling with MDD.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ABM + | Experimental | Attention Bias Modification |
|
| ABM - | Sham Comparator | Sham Attention Bias Modification |
|
| ABM + and ACT | Experimental | Attention Bias Modification followed by Group Acceptance and Commitment Therapy |
|
| ABM - and ACT | Sham Comparator | Sham Attention Bias Modification followed by Group Acceptance and Commitment Therapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Attention Bias Modification | Behavioral | Computer based Attention Bias Modification |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in residual symptoms of depression - self report | Change in residual symptoms of depression as measured by Beck Depression Inventory | Will be measured at Baseline, immediately after ABM-intervention, then after 1 month, 2 months, 6 months, and 12 months |
| Change in residual symptoms of depression - clinician rating | Change in residual symptoms of depression as rated by Hamilton Rating Scale for Depression | Will be measured at Baseline, immediately after ABM-intervention, then after 1 month, 2 months, 6 months, and 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Recurrence of major depressive episodes | Measured by MINI structured interview | Will be measured 12 months after baseline |
| Changes in Cortisol response | Cortisol measured in salvia. Samples taken in the morning on three days in succession. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Vegard Ø Haaland, PhD | Sorlandet Hospital HF | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sørlandet Hospital, Department of Psychiatry | Arendal | Aust-Agder | 4801 | Norway | ||
| University of Oslo, Department of Psychology |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29587807 | Derived | Ostergaard T, Lundgren T, Zettle R, Jonassen R, Harmer CJ, Stiles TC, Landro NI, Haaland VO. Acceptance and Commitment Therapy preceded by an experimental Attention Bias Modification procedure in recurrent depression: study protocol for a randomized controlled trial. Trials. 2018 Mar 27;19(1):203. doi: 10.1186/s13063-018-2515-9. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003865 | Depressive Disorder, Major |
| ID | Term |
|---|---|
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D064869 | Acceptance and Commitment Therapy |
| ID | Term |
|---|---|
| D015928 | Cognitive Behavioral Therapy |
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided
| OTHER |
| The Hospital of Vestfold | OTHER |
Not provided
Not provided
Not provided
Not provided
| Sham Attention Bias Modification | Behavioral | Computer based Sham Attention Bias Modification |
|
|
| Acceptance and Commitment Therapy | Behavioral | Acceptance and Commitment Therapy delivered in a group therapy setting |
|
|
| Will be measured at Baseline, immediately after ABM-intervention, then after 1 month, 2 months, 6 months, and 12 months |
| Changes in symptoms of anxiety - self report | Change in symptoms of anxiety as measured by Beck Anxiety Inventory | Will be measured at Baseline, immediately after ABM-intervention, then after 1 month, 2 months, 6 months, and 12 months |
| Changes in Quality of Life - self report | WHOQOL-BREF | Will be measured at Baseline, then after 2 months, 6 months, and 12 months |
| Changes in Acceptance - self report | The 7-item Acceptance and Action Questionnaire - II (AAQ-II) | Will be measured at Baseline, then after 1 month, 2 months, 6 months, 12 months |
| Changes in Values - self report | Bulls Eye | Will be measured at Baseline, then after 1 month, 2 months, 6 months, 12 months |
| Changes in Values and committed action - self report | Engaged living scale | Will be measured at Baseline, then after 1 month, 2 months, 6 months, 12 months |
| Changes in Emotional, Psychological and Social Well-Being - self report | Mental Health continuum - short form | Will be measured at Baseline, then after 1 month, 2 months, 6 months, 12 months |
| Changes in Present-moment awareness and acceptance - self report | Philadelphia mindfulness scale | Will be measured at Baseline, then after 1 month, 2 months, 6 months, 12 months (only in ACT-arms) |
| Changes in Cognitive fusion - self report | Cognitive fusion questionnaire | 1 month, 2 months, 6 months, 12 months (only in ACT-arms) |
| Oslo |
| 0317 |
| Norway |